Demographics, clinical features, and prognosis of rare lymphoepithelioma-like carcinoma across different anatomic sites

Journal of the Egyptian National Cancer Institute

Table 4 Survival analysis for patients presenting with localized disease

Site	Unadjusted model: crude hazard ratio (95% CI)	P	Model 1^a: hazard ratio (95% CI)	P
Nasopharynx	1	Ref	1	Ref
Salivary gland	0.62 (0.38–1.03)	0.063	0.8 (0.43–1.49)	0.487
Tonsil	0.81 (0.33–2.01)	0.653	0.91 (0.34–2.39)	0.841
Lung and bronchus	2.16 (1.28–3.63)	0.004	3.12 (1.55–6.26)	0.001
Urinary bladder	0.51 (0.12–2.08)	0.346	0.81 (0.18–3.68)	0.789
Female genital system	0.5 (0.22–1.16)	0.109	1.09 (0.402–2.95)	0.867
Digestive system	1.82 (0.93–3.56)	0.08	1.93 (0.85–4.42)	0.118

Abbreviations: CI confidence interval, Ref reference group
^aModel 1: Full model. Adjusted by year of diagnosis, age (continuous variable), sex, race, grade, and treatment